Roberta Francesca Capogrosso

Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse

Jonathon M. Tinsley, Rebecca J. Fairclough, Richard Storer et al. · PLoS ONE · 2011 · 172 citations · Full text

Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests

Rosa Burdi, Jean‐François Rolland, B. Fraysse et al. · Journal of Applied Physiology · 2009 · 82 citations

Muscle Function, Pathology, Neuromusculoskeletal Disorder +20

Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice

Anna Cozzoli, Beatrice Nico, Valeriana Sblendorio et al. · Pharmacological Research · 2011 · 68 citations · Full text

Cardiovascular Pharmacology, Pharmacotherapy, Dystrophic Mdx Mice +24

Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin‐deficient <i>mdx</i> mice: proof‐of‐concept study and independent validation of efficacy

Roberta Francesca Capogrosso, Paola Mantuano, Kitipong Uaesoontrachoon et al. · The FASEB Journal · 2017 · 57 citations · Full text

GLPG0492, a novel selective androgen receptor modulator, improves muscle performance in the exercised-mdx mouse model of muscular dystrophy

Anna Cozzoli, Roberta Francesca Capogrosso, Valeriana Sblendorio et al. · Pharmacological Research · 2013 · 56 citations

Molecular Pharmacology, Muscle Function, Kinesiology +11